Gowramma Byran

1.2k total citations
82 papers, 811 citations indexed

About

Gowramma Byran is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Gowramma Byran has authored 82 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 19 papers in Molecular Biology and 17 papers in Computational Theory and Mathematics. Recurrent topics in Gowramma Byran's work include Synthesis and biological activity (32 papers), Computational Drug Discovery Methods (17 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Gowramma Byran is often cited by papers focused on Synthesis and biological activity (32 papers), Computational Drug Discovery Methods (17 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Gowramma Byran collaborates with scholars based in India, Bangladesh and Malaysia. Gowramma Byran's co-authors include Kalirajan Rajagopal, Jubie Selvaraj, Srikanth Jupudi, Suresh Balakrishnan, Praveen Thaggikuppe Krishnamurthy, Vadivelan Ramachandran, B. Babu, S. N. Meyyanathan, Elango Kandasamy and Arun Radhakrishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Applied Biochemistry and Biotechnology.

In The Last Decade

Gowramma Byran

74 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gowramma Byran India 15 338 206 166 89 85 82 811
Muhammad Khattab Egypt 14 335 1.0× 281 1.4× 188 1.1× 49 0.6× 82 1.0× 28 878
Radwan Alnajjar Libya 17 475 1.4× 295 1.4× 259 1.6× 48 0.5× 138 1.6× 72 1.0k
Richie R. Bhandare United Arab Emirates 21 750 2.2× 314 1.5× 188 1.1× 68 0.8× 60 0.7× 59 1.2k
Mehreen Ghufran Pakistan 19 462 1.4× 231 1.1× 119 0.7× 45 0.5× 111 1.3× 39 857
Ayman Abo Elmaaty Egypt 20 453 1.3× 345 1.7× 199 1.2× 48 0.5× 134 1.6× 54 1000
Kalirajan Rajagopal India 16 520 1.5× 300 1.5× 222 1.3× 78 0.9× 109 1.3× 97 1.0k
Sujata K. Dass India 17 217 0.6× 193 0.9× 100 0.6× 33 0.4× 61 0.7× 32 681
Manikanta Murahari India 23 334 1.0× 468 2.3× 270 1.6× 63 0.7× 164 1.9× 51 1.2k
Ayon Chakraborty India 14 147 0.4× 289 1.4× 226 1.4× 88 1.0× 137 1.6× 30 807
Sarfaraz Alam India 18 453 1.3× 384 1.9× 222 1.3× 41 0.5× 96 1.1× 40 1.0k

Countries citing papers authored by Gowramma Byran

Since Specialization
Citations

This map shows the geographic impact of Gowramma Byran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gowramma Byran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gowramma Byran more than expected).

Fields of papers citing papers by Gowramma Byran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gowramma Byran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gowramma Byran. The network helps show where Gowramma Byran may publish in the future.

Co-authorship network of co-authors of Gowramma Byran

This figure shows the co-authorship network connecting the top 25 collaborators of Gowramma Byran. A scholar is included among the top collaborators of Gowramma Byran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gowramma Byran. Gowramma Byran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balachandran, H., et al.. (2025). A Recent Progress in Biological Activities of 1,3,4-thiadiazole and its Derivatives: A Review. Current Topics in Medicinal Chemistry. 25(15). 1810–1867. 1 indexed citations
2.
Das, Sukhen, Gowramma Byran, Kaushik Biswas, & Kalirajan Rajagopal. (2025). Understanding Tankyrase Inhibitors and Their Role in the Management of Different Cancer. Current Cancer Drug Targets. 25(12). 1506–1517.
3.
Rajagopal, Kalirajan, Fahadul Islam, Mehrukh Zehravi, et al.. (2024). Potential Inhibitors from Natural Compounds against SARS‐CoV‐2 Main Protease: A Systematic Molecular Modelling Approach. ChemistrySelect. 9(7). 2 indexed citations
4.
Byran, Gowramma, et al.. (2024). Targeting STAT3 Enzyme for Cancer Treatment. Mini-Reviews in Medicinal Chemistry. 24(13). 1252–1261.
5.
6.
Li, Yunwei, et al.. (2022). Identification of Selective PPAR-γ Modulators by Combining Pharmacophore Modeling, Molecular Docking, and Adipogenesis Assay. Applied Biochemistry and Biotechnology. 195(2). 1014–1041. 8 indexed citations
7.
Rajagopal, Kalirajan, Fahadul Islam, Manish Dhawan, et al.. (2022). Role of natural products towards the SARS-CoV-2: A critical review. Annals of Medicine and Surgery. 80. 104062–104062. 12 indexed citations
8.
Subramanian, Gomathy Sandhya, et al.. (2022). DOCKING STUDIES AND SYNTHESIS OF NOVEL 4- THIAZOLIDINONE DERIVATIVES BEARING 1, 3, 4- OXADIAZOLE MOIETY AS SIRT-3 ACTIVATORS TARGETING PARKINSON’S DISEASE. RASAYAN Journal of Chemistry. 15(1). 483–496. 1 indexed citations
9.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2021). 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 21(15). 2050–2065. 10 indexed citations
10.
Jupudi, Srikanth, Kalirajan Rajagopal, Sankaranarayanan Murugesan, et al.. (2021). Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach. South African Journal of Botany. 151. 82–91. 14 indexed citations
11.
Rajagopal, Kalirajan, et al.. (2020). Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach. SHILAP Revista de lepidopterología. 6(1). 104–104. 96 indexed citations
12.
Byran, Gowramma, et al.. (2019). Oral Modified Drug Release Solid Dosage Form with Special Reference to Design; An Overview. PubMed. 12(1). 16–25. 24 indexed citations
13.
Babu, B., et al.. (2017). Development and validation of stability indicating liquid chromatography tan-dem mass spectrometry method for the determination of Dasatinib in bulk. International Journal of Research in Pharmaceutical Sciences. 8(4). 663–666. 1 indexed citations
14.
Yamjala, Karthik, et al.. (2017). Simultaneous Determination of Atorvastatin, Metformin and Glimepride in Pharmaceutical Dosage Form by a Stability Indicating RP HPLC Method. Journal of chemical and pharmaceutical research. 9(1).
15.
Byran, Gowramma, et al.. (2015). DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF QUERCETIN AND RUTIN FROM AGANOSMA DICHOTOMA [ROTH] K. SCHUM. Indo American Journal of Pharmaceutical Research. 5(11). 3412–3417. 1 indexed citations
16.
Meyyanathan, S. N., et al.. (2015). A NEW VALIDATED CHIRAL RP-HPLC METHOD FOR THE DETERMINATION OF STABILITY OF MEBEVERINE ENANTIOMERS IN THE PRESENCE OF ITS DEGRADATION PRODUCTS. International Journal of Pharmacy and Pharmaceutical Sciences. 7(5). 112–116. 4 indexed citations
17.
Selvaraj, Jubie, et al.. (2015). Synthesis and antimicrobial activity of some novel ciprofloxacin analogues. Journal of Pharmacy Research. 511–513. 6 indexed citations
18.
19.
Byran, Gowramma & S. N. Meyyanathan. (2013). DEVELOPMENT AND VALIDATION OF LC-MS/MS METHOD FOR THE ESTIMATION OF ZALTOPROFEN ENANTIOMERS IN PHARMACEUTICAL FORMULATION. International Journal of Pharma and Bio Sciences. 4(1). 883–889. 3 indexed citations
20.
Rajagopal, Kalirajan, et al.. (2010). Microwave Assisted Synthesis and Biological Evaluation of Pyrazole Derivatives of Benzimidazoles. Indian Journal of Pharmaceutical Education and Research. 44(4). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Khattab Breakdown of academic impact, for papers by Radwan Alnajjar Breakdown of academic impact, for papers by Richie R. Bhandare Breakdown of academic impact, for papers by Mehreen Ghufran Breakdown of academic impact, for papers by Ayman Abo Elmaaty Breakdown of academic impact, for papers by Kalirajan Rajagopal Breakdown of academic impact, for papers by Sujata K. Dass Breakdown of academic impact, for papers by Manikanta Murahari Breakdown of academic impact, for papers by Ayon Chakraborty Breakdown of academic impact, for papers by Sarfaraz Alam
Rankless by CCL
2026